Clinical Trials Browser

Phase 2/3 × Interventional × Diarrhea × Clear all

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Phase 2/3 Unknown

Breast Neoplasms, Diarrhea

NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

Phase 2/3 Completed

Gastrointestinal

Diarrhea, Neutropenia, Colorectal Neoplasms